Effects of Ningdong granule on DA, DRD2, and HVA in a rat model of Tourette's syndrome  by LV, Hong et al.
JTCM |www. journaltcm. com June 15, 2012 |volume 32 | Issue 2 |
Online Submissions: http://www.journaltcm.com J Tradit Chin Med 2012 June 15; 32(2): 283-288
info@journaltcm.com ISSN 0255-2922
© 2012 JTCM. All rights reserved.
Basic Investigation
Effects of Ningdong granule on DA, DRD2, and HVA in a rat model of
Tourette’s syndrome
LV Hong吕红, LIN Hai-yan林海燕, ZHAO Hui赵辉, LI An-yuan李安源, LIN Ying林莺, YAO Bing姚冰
aa
LV Hong, LIN Hai-yan, LIN Ying, TCM College of Binzhou
Medical University, Yantai, Shandong 264003, China
ZHAO Hui, Pharmaceutical Sciences College of Binzhou
Medical University, Yantai, Shandong 264003, China
LI An-yuan, TCM Department, Shandong University Affiliat-
ed Provincial Hospital, Jinan, Shandong 250021, China
YAO Bing, Yantai Governmental Hospital, Yantai, Shandong
264000, China
Supported by Binzhou Medical University (NO. BY2010KY-
QD13)
Correspondence to: Prof. Lin Hai-yan, TCM College of Bin-
zhou Medical University, Yantai, Shandong 264003, China.
zhongyaoyaoli2007@163.com
Telephone: +86-15192358677
Accepted: July 07, 2011
Abstract
OBJECTIVE: Ningdong granule is a traditional Chi-
nese medicine preparation for the treatment of To-
urette's syndrome.
METHODS: Sixty-four rats were randomly assigned
to a control group and three experimental groups,
respectively. Rat models of Tourette's syndrome
were established via intraperitoneal injection of
apomorphine (Apo). The rats in the experimental
groups were subsequently intragastrically injected
with haloperidol at 10 mg/kg (haloperidol group),
Ningdong granule at 370 mg/kg (NDG group), and
normal saline (0.9% ) at 10 mL/kg (Apo group), re-
spectively. Rat behaviors were observed and re-
corded on a daily basis. After 12 w, all rats were sac-
rificed, and sera and striatal tissues were harvested.
Homovanillic acid levels in sera, as well as dopa-
mine and dopamine D2 receptor mRNA expression
in the striatum, were measured to determine possi-
ble mechanisms of Ningdong granule on the dopa-
mine system in a rat model of Tourette's syndrome.
RESULTS: Following intervention, stereotype ac-
tions of the Tourette's syndrome rats were signifi-
cantly inhibited in the haloperidol and NDG
groups, respectively (P<0.01). Homovanillic levels
were significantly greater in the haloperidol and
NDG groups, respectively (P<0.05). In addition, do-
pamine levels were significantly less in the NDG
group (P<0.01), and DRD2 mRNA expression was
significantly reduced in the haloperidol and NDG
groups, respectively (P<0.05).
CONCLUSION: Results demonstrated that Ning-
dong granule effectively inhibited stereotype ac-
tions and Tourette's syndrome symptoms by pro-
moting dopamine metabolism, reducing dopa-
mine levels in the striatum, increasing homovanillic
acid content in sera, and reducing mRNA expres-
sion of DRD2 in the striatum.
© 2012 JTCM. All rights reserved.
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INTRODUCTION
Tourette's syndrome (TS) is a neuropsychiatric disor-
der characterized by stereotypic, involuntary, purpose-
less, and repetitive movements. The typical motor tics
include headshakes and violent clonic tics comprising
thrusting head jerks, as well as orofacial tics, such as fa-
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cial grimacing, eye blinking, and throat clearing[1]. The
prevalence of this syndrome is estimated at 4-6 per
1000 children and adolescents[2]. Initial TS symptoms
often occur around the age of 7 years[1], and the disease
occurs 3-4 times more often in males than in females[3].
For some individuals, tics result in lifelong impair-
ment, and 5% of TS patients exhibit life-threatening
symptoms that are defined as malignant TS[4]. In the
clinic, Ningdong granule (NDG), a TCM preparation,
has been used as an anti-tic agent for years. A previous
study from our group showed that the total effective
rate of NDG for TS is 83.3%-73.3% [5]. The present
study analyzed possible mechanisms of NDG on the
DA system in a rat model of TS.
MATERIALS ANDMETHODS
Drugs and reagents
The mixed NDG formula powder was provided by
999 Modern Chinese Medicine (Shenzhen, China).
The eight traditional herbs, which comprise NDG, are
shown in Table 1. The raw herbs were dried at the her-
barium and were subsequently mixed in proportion
and macerated for 1 h at room temperature with dis-
tilled water. Then, the entire mixture was decocted
twice for 1 h each. The filtrates were mixed and con-
densed and subsequently dried using a vacuum-drier at
60°C. The yield granule was stored at 4°C.
Table 1 Ningdong granule composition and active ingredients
Composition
Gastrodia elata Blume
(Orchidaceae)
Uncariae rhynchophylla
Lignsticum chuanxiong
concha haliotidis
Buthus martensii karach
Scolopendra subspinipes
mutilans L. KOCH
Placenta Hominis dried human
placenta
Glycyrrhiza uralensis, G. glabra
Active ingredients
4-hydroxybenzaldehyde; p-hydroxybenzyl alcohol; gastrodin; parishin;
4, 4-dihydroxybenzyl sulfoxide
rhynchophylline; isorhynchophylline; isocorynoxeine
ferulic acid; senkyunolide; ligustilide; tetramethylpyrazine
calcium carbonate; iron; phosphate radical; silicate; etc.
uthotox; trimethylamine; taurine; betaine; hexadecanoic acid;
octadecanoic acid, etc.
3,8-dihydroxyquinoline; 8-hydroxy-1H-2-benzopyran-1-one
Luteosterone; tetrahydrocorticosterone; amino acids; etc.
glycyrrhizin; liquiritin; liquiritin apioside; isoliquiritin; isoliquiritin
apioside; liquiritigenin
Amount used (g)
6
20
6
20
3
3
3
Animals and materials
Wistar rats (male, 4 w old, 100±20 g) were purchased
from Shandong Experimental Animal Center (Jinan,
China). APO was purchased from Sigma (Santa Clara,
CA, USA). Haloperidol was purchased from Shanghai
Pharmaceutical Group (Shanghai, China). NDG was
provided by 999 Modern Chinese Medicine (Shen-
zhen, China). Trizol, RevertAidTM First Strand cDNA
Synthesis Kit, TaKaRa TaqTM Hot Start Version, and
Enzyme Immunoassay Kit were purchased from Invit-
rogen (New York, NY, USA), Fermentas (Glen Burnie,
MD, USA), Takara Biotechnology (Dalian, China),
Adlitteram Diagnostic Laboratories (Los Angeles, CA,
USA), respectively. The Gene ampR PCR System was
supplied by Applied Biosystems (Los Angeles, CA,
USA). The microtiter plate reader was purchased from
Molecular Devices (Los Angeles, CA, USA).
Establishment of rat models of TS
The rats were housed in an air-conditioned animal
room with 12 h light/dark cycle, 22±2°C, and 50±10%
humidity. The rats were fed a laboratory diet and water
ad libitum, and were housed for 1 w prior to the start
of the experiment. After 1 w, the rats were randomly as-
signed to four groups: control, Apo, haloperidol, and
NDG. Rats in the experimental groups were intraperi-
toneally injected with Apo (2 mg/kg/d), and rats in the
control group were injected with normal saline (0.9%;
5 mL/kg/d). Rat behaviors were observed on a daily ba-
sis by researchers not familiar with the experimental de-
sign. One-minute intervals were observed every 5 min
for a total of six intervals. Stereotypy actions were ob-
served, which included bites (teeth touching the cage,
wood chips, vacuous chewing), taffy pulling (forepaw
raising), self-gnawing, licking not associated with
grooming, head shaking, paw buffeting, quick aversion
episodic utterances, etc. Scores ranging from 0 to 5
were averaged for each group. The standard was as fol-
lows: 0– asleep, resting in place or normal activity in
place; 1– increased sniffing and head raising; 2– dis-
continuous increased sniffing with body raising; 3–
discontinuous increased sniffing, licking with head and
body raising primarily in one place, with occasional
rapid burst of locomotor activity (2-5 steps); 4– con-
tinuous sniffing, biting, head bobbing and repetitive
body raising/wall climbing in place; 5– Continuous
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sniffing, biting, licking, head bobbing, and continuous
body raising/wall climbing while the forepaws did not
touch the cage floor. Animal handling was in accor-
dance with the American Physiological Society "Guid-
ing Principles in the Care and Use of Animals."
Intervention therapy
Haloperidol group rats were intragastrically injected
with haloperidol (10 mg/kg), NDG group rats were in-
jected with NDG (370 mg/kg; equal to 15-fold clinical
dose), Apo group rats were injected with normal saline
(0.9%; 10 mL/kg) once daily for 12 w. Rat behaviors
were observed and recorded on a daily basis. After 12
w, the rats were sacrificed. Blood samples were collect-
ed and striatal tissues were isolated according to Paxi-
nos and Watson's stereotaxic atlas of the rat brain [6].
HVA levels in sera and DA in the striatum
Sera levels of HVA and striatal DA content were mea-
sured using a sandwich enzyme-linked immunosorbent
assay (ELISA) according to manufacturer instructions.
Briefly, antigen standards and samples were added to
each well of a 96-well plate pre-coated with primary an-
tibodies. Following addition of biotin-conjugate re-
agent and enzyme-conjugate reagent into each well, the
plates were incubated at 37°C for 60 min. The plates
were then rinsed 5 times with distilled water. Within
30 min of the chromogenic reaction (The chromogen-
ic reaction was a internal program in the microplate
reader. Once the microtiter plate was put into the mi-
croplate reader, the chromogenic reaction will react au-
tomaticly.), absorbance was measured at 405 nm using
a microtiter plate reader.
DRD2 mRNA expression in the striatum
DRD2 mRNA expression in the striatum was deter-
mined using reverse transcriptase-polymerase chain re-
action (RT-PCR). Striatal samples were homogenized,
and total RNA was extracted using a Trizol reagent ac-
cording to manufacturer instructions. DRD2 primers
were as follows: forward primer 5'-CTG GTA ATG
CCG TGG GTT-3' and reverse primer 5'-CAG GGT
GGG TAC AGT TGC-3' (487 bp) (AJ347728). β-ac-
tin primers were as follows: forward primer 5'-CCT
GTG GCA TCC ATG AAA CTAC-3' and reverse
primer 5'-CTT CTG CAT CCT GTC AGC AAT-3'
(134 bp) (NM031144). The PCR protocol comprised
an initial denaturation step at 94°C for 30 s, followed
by 30 cycles of amplification. For cDNA amplification,
the cycles consisted of denaturation at 94°C for 30 s,
annealing at 58°C for 30 s, and elongation at 72°C for
30 s. For amplification of β-actin cDNA, the cycles in-
cluded denaturation at 94° C for 30 s, annealing at
56°C for 30 s, and elongation at 72°C for 30 s. To veri-
fy amplification specificity, PCR products were separat-
ed by electrophoresis on a 1.5% agarose gel, which was
then stained with ethidium bromide and examined us-
ing an AlphaImager 2200 image analysis system (Al-
phaimager 2200 Pharmacia, Santa Clara, CA, USA).β-actin was used as an internal control for each sample.
Statistical analysis
Data were expressed as mean±standard deviation (SD).
Statistical analysis was performed by one-way analysis
of variance. All analyses were performed using SPSS
statistical software package (Version 13.0, SPSS, Chica-
go, IL, USA), and P<0.05 was considered statistically
significant.
RESULTS
Behavior study
Figure 1 Effect of NDG on rat stereotype actions. Data are ex-
pressed as the mean±SD (n=16 rats/group). ##P<0.01, vs. the
control group. **P<0.01, vs. the Apo group.
Apo induces stereotype actions (P<0.01), and actions
in the Apo group were significantly greater than in the
control group (P<0.01). Stereotype actions are signifi-
cantly inhibited by NDG and haloperidol (P<0.01).
However, there is no significant difference between the
haloperidol and NDG groups (P>0.05).
Levels of HVA in sera and DA in striatum
Figure 2 Effect of NDG on sera HVA content in rats. ##P<0.01,
vs. the control group. *P<0.05, vs. the APO group.
HVA content in the Apo group is significantly less
than in the control group (3.49±0.66 mg/mL vs. 4.76±
0.85 mg/mL, P<0.01). In the NDG and haloperidol
groups, HVA levels are significantly greater than in the
Apo group (4.81±1.36 mg/mL vs. 3.49±0.66 mg/mL,
4.86 ± 1.48 mg/mL vs. 3.49 ± 0.66 mg/mL, P<0.05).
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There is no significant difference between haloperidol
and NDG groups (P>0.05).
Figure 3 Effect of NDG on DA content in rats. ##P<0.01, vs.
the control group. **P<0.01, vs. the APO group. *P<0.05, vs.
the haloperidol group.
DA content in the Apo group is significantly greater
than in the control group (240.24 ± 72.32 ng/mL vs.
130.42±44.39 ng/mL, P<0.01). NDG significantly de-
creases DA content (136.04±50.95 ng/mL vs. 240.24±
72.32, P<0.01), but not haloperidol (197.36 ± 103.85
ng/mL vs. 240.24±72.32, P>0.05), compared with the
Apo group. However, the NDG group has significantly
less DA than the haloperidol group (P<0.05).
Expression of DRD2 mRNA in the striatum
Figure 4 Effect of NDG on DRD2 mRNA expression in the stri-
atum. ##P<0.01 , vs. the control group. *P<0.05 , vs. the APO
group.
Striatal DRD2 mRNA expression was analyzed by
RT-PCR. Results show that DRD2 mRNA expression
in striatum is significantly increased in the Apo group
compared with the control group (P<0.01). In the
NDG and haloperidol groups, DRD2 mRNA expres-
sion is significantly greater than in the Apo group (P<
0.05). There is no significant difference between halo-
peridol and NDG groups (P>0.05).
DISCUSSION
The pathophysiology and etiology of TS remain poorly
understood. However, previous results have suggested
that abnormalities in DA neurotransmission play a role
in TS pathophysiology[7]. DA, which is released by
nerve terminals originating from midbrain neurons,
modulates striatal neuronal activity by stimulating DA
receptors[8]. Two families of DA receptors, called
D1-like receptor (DRD1) and D2-like receptor
(DRD2), exist[9], and the DA transporters (DAT)
DRD1 and DRD2 have been shown to increase densi-
ties in the frontal cortex of TS patients when compared
to matched controls[10]. Results have shown that densi-
ties of prefrontal DRD2 are increased by 140% com-
pared to matched controls[11]. In addition, autopsy re-
sults have suggested increased DRD2 activity in TS pa-
tients[12]. The development of TS symptoms has been
shown to be influenced by genetic factors. Indeed, heri-
table differences in forebrain DRD2 function might
contribute to TS[13]. As the primary DA metabolite in
the central neural system, HVA is generally regarded as
a major indicator of DA activity[14]. A previous study
showed that HVA levels in patients is significantly less
than in the control group[15]. Together, these results sug-
gest that TS correlates with DA content and activity, as
well as DRD2 density and sensitivity in the striatum.
Previous results have suggested that inhibition of DA
receptors, in particular DRD2, by receptor antagonists
reduces tic frequency and severity[16]. Haloperidol is a
US Food and Drug Administration-approved treat-
ment for TS symptoms and other tic disorders. It selec-
tively curbs activity of the post-synaptic DA receptor
and inhibits excitability of the cortical motor area by
decreasing DA receptor activity, thereby weakening TS
symptoms[17]. Although haloperidol is efficacious for
the treatment of TS, a very high proportion of patients
eventually discontinue therapy due to negative side ef-
fects, including sedation, weight gain, extrapyramidal
symptoms, and heart QT interval prolongation[18].
Therefore, the development of novel drugs for TS treat-
ment is crucial.
NDG components are thought to work together to in-
duce anti-tic effects. Results from the present study
showed that NDG effectively inhibited stereotype ac-
tions and controlled TS symptoms by promoting DA
metabolism, reducing DA content in the striatum, in-
creasing HVA levels in sera, and inhibiting DRD2
mRNA expression.
Hyperfunction of the DA system plays an important
role in TS etiopathogenesis. DA content and activity,
as well as DRD2 density and sensitivity in the stria-
tum, correlated with TS. It is well known that DA is
synthesized and released into the synaptic cleft, result-
ing in a significant effect only after combining with
DRD2. Following DAT re-uptake, DA transforms into
HVA in neurons and is released into the blood. Previ-
ous studies have shown that Gastrodia elata Blume, a
main component of NDG, inhibits activity of dopami-
nergic neurons, decreases DA reuptake, reduces DA
content, and adjust catecholamine in the nervous sys-
tem[19]. Uncariae rhynchophylla and Lignsticum ch-
uanxiong have been reported that they can reduce excit-
ability of the rat cerebral cortex, and inhibit spontane-
ous movement in rats[20,21]. In the present study, TS rats
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were treated with NDG and the curative effects were
compared with haloperidol. Results demonstrated that
NDG significantly reduced DA content in the stria-
tum of TS rats and increased transformation into
HVA, thereby reducing TS symptoms.
Haloperidol, a common medication for TS, reduces tic
frequency and severity and increases HVA levels[16,22].
Results from the present study showed that NDG also
increased HVA levels and improved stereotype actions
in APO-induced TS rats. In addition, NDG exhibited
similar effects on HVA and stereotype actions with hal-
operidol. Both drugs promoted DA transformation in-
to HVA. However, a unified conclusion about the ef-
fect of haloperidol on DA levels does not exist [22,23]. Re-
sult from the present study showed that haloperidol
had no effect on DA levels, but NDG decreased DA
concentrations in the striatum, which suggested differ-
ent effects of NDG and haloperidol on DA metabo-
lism. DRD2 is a type of G-protein-coupled receptor,
and excitable activity occurs after DA binds to DRD2.
For instance, high DRD2 activity has been shown to
result in tics. In this study, DRD2 mRNA expression
significantly decreased in the striatum of the NDG and
haloperidol groups compared with the APO group.
These results were consistent with previous results[24].
The present study had several limitations. First, the
study was a preliminary study and it was difficult to
completely reproduce human pathogenesis. Second,
the limited sample size could, in part, contribute to the
lack of significant findings. Finally, the present study
was an in vivo experimental rat study and caution
should be exercised when translating these results to
human clinical situation. Future studies should also an-
alyze the effects of Rhynchophylline on DA system.
In summary, results from the present study suggested
that NDG effectively inhibited stereotype actions and
controlled TS symptoms by promoting DA metabo-
lism, reducing DA content in the striatum, increasing
HVA content in sera, and inhibiting DRD2 mRNA ex-
pression.
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